Pexidartinib 11014-0481-01
- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- October 14, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pexidartinib Hydrochloride | 125 mg/1 |
Selected Package
11014-0481-01Selected1 BAG in 1 DRUM (11014-0481-1) / 40004 CAPSULE in 1 BAG